V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280012065 | 280009070 | null | 71.6 | Curative (C) | 2016-03-04 | 2016-03-27 | Cisplatin | 02 | N | 280028292 | CISPLATIN |
| 280012066 | 280005860 | 1.71 | 78.7 | Palliative (P) | null | 2016-04-07 | CARBOPLATIN + PACLITAXEL | 02 | null | 280028302 | CARBOPLATIN + PACLITAXEL |
| 280012067 | 280005943 | 1.65 | 85 | Curative (C) | 2016-07-16 | 2016-07-16 | VAI (Ifos 3g/m2) | null | null | 280028576 | IRINOTECAN + MDG |
| 280012068 | 280005984 | 1.75 | 65 | Curative (C) | null | 2014-12-21 | GEMCITABINE | N | null | 280028712 | GEMCITABINE |
| 280012069 | 280005999 | 1.81 | 80.8 | null | 2016-08-22 | 2016-08-22 | EURO-EWING | 02 | N | 280028766 | EURO-EWING |
| 280012070 | 280006054 | 1.81 | 76.5 | Palliative (P) | 2017-11-15 | 2017-12-30 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 280028989 | CISPLATIN + GEMCITABINE |
| 280012071 | 280006068 | 1.66 | null | Palliative (P) | 2017-07-25 | 2018-03-07 | EW EuroEwing 99 : VActI | N | N | 280029015 | EURO-EWING |
| 280012072 | 280006085 | 1.86 | 93 | Palliative (P) | 2015-09-28 | 2015-10-19 | Carboplatin + Paclitaxel (weekly) | 02 | N | 280029057 | CARBOPLATIN + PACLITAXEL |
| 280012073 | 280011937 | 1.67 | 94.7 | Palliative (P) | 2018-09-15 | 2018-09-21 | DE-ESCALATE TRIAL | 02 | N | 280029101 | DE-ESCALATE TRIAL |
| 280012074 | 280009243 | 1.72 | 79.2 | Curative (C) | null | 2019-08-15 | VAC | 02 | null | 280029471 | CAV |
| 280012075 | 280006326 | 1.67 | 60.4 | Curative (C) | null | 2017-12-29 | Doxorubicin + Olaratumab | N | N | 280029968 | DOXORUBICIN + OLARATUMAB |
| 280012076 | 280006352 | null | 72.6 | Palliative (P) | 2020-09-02 | 2020-09-02 | NIVOLUMAB | N | N | 280030055 | BCG |
| 280012078 | 280006424 | null | 67 | Palliative (P) | 2014-05-27 | 2014-06-08 | IVADo | N | N | 280030215 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280012079 | 280006442 | 0 | 22.6 | Palliative (P) | 2018-11-03 | 2019-07-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL + RT | 02 | N | 280030268 | DACTINOMYCIN + VINCRISTINE |
| 280012080 | 280006480 | 1.54 | 72 | Palliative (P) | 2019-06-11 | 2019-08-09 | CARBOPLATIN + CETUXIMAB + FU | 02 | N | 280030373 | LIPOSOMAL DOXORUBICIN |
| 280012081 | 280006511 | 0 | 85.8 | Curative (C) | 2014-07-21 | 2014-08-30 | CAPECITABINE + TEMOZOLOMIDE | N | N | 280030483 | MITOMYCIN INTRAVESICULAR |
| 280012082 | 280012086 | 1.82 | 69.3 | Palliative (P) | 2018-07-03 | 2018-07-03 | PEMBROLIZUMAB | 02 | N | 280030581 | IFOSFAMIDE + VINCRISTINE |
| 280012083 | 280006575 | 1.7 | 56.8 | Palliative (P) | 2019-06-17 | 2019-06-20 | VINCRISTINE | null | null | 280030705 | BCG |
| 280012084 | 280006631 | 1.74 | 65 | Palliative (P) | 2018-11-20 | 2019-07-09 | ICE + GCSF | N | N | 280019073 | BUSULFAN + MELPHALAN |
| 280012085 | 280010809 | null | 61.6 | Palliative (P) | 2016-07-17 | 2016-07-23 | OCTREOTIDE | N | N | 280020096 | CISPLATIN + FLUOROURACIL + RT |
| 280012086 | 280011477 | 1.62 | 63.7 | Disease modification (D) | 2019-05-18 | 2019-05-18 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280020669 | CARBO + FLUOROURACIL |
| 280012087 | 280006714 | 1.63 | 56.8 | Neo-adjuvant (N) | 2015-10-12 | 2015-10-12 | VIDE | N | N | 280023280 | KESTREL TRIAL |
| 280012088 | 280006790 | 1.61 | 85.8 | Curative (C) | 2020-02-09 | 2020-03-03 | Cyclophosphamide + Vincristine | N | N | 280026551 | VINORELBINE |
| 280012090 | 280004708 | 1.72 | 88 | Curative (C) | 2017-06-09 | 2017-08-09 | Carboplatin AUC 2 - 5 | N | Y | 280024610 | CARBOPLATIN |
| 280012091 | 280004795 | 1.75 | 71.4 | Adjuvant (A) | 2019-02-16 | 2019-03-03 | Cetuximab 7 day (>Cycle 2) | Y | N | 280024836 | CETUXIMAB |
| 280012092 | 280008556 | 1.62 | 80 | Palliative (P) | 2018-08-16 | 2018-10-18 | Carboplatin AUC 2 - 5 | N | N | 280024896 | CARBOPLATIN |
| 280012093 | 280008567 | 0 | 48.9 | Palliative (P) | null | 2015-11-01 | EW EuroEwing 2012 Arm A VAC | null | null | 280024927 | NOT MATCHED |
| 280012094 | 280011227 | 1.61 | 73.4 | Palliative (P) | 2015-12-30 | 2016-01-18 | CETUXIMAB | N | null | 280025130 | CETUXIMAB |
| 280012095 | 280005180 | null | null | Neo-adjuvant (N) | 2017-12-05 | 2018-01-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025794 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280012096 | 280008757 | 1.8 | null | Palliative (P) | 2015-02-12 | 2015-02-12 | Ifosfamide | N | N | 280025900 | IFOSFAMIDE |
| 280012097 | 280005415 | 0 | 64.2 | Palliative (P) | 2015-06-04 | 2015-06-07 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 280026704 | IVA |
| 280012098 | 280005439 | 1.65 | 59.6 | Palliative (P) | 2015-11-13 | 2015-12-22 | Doxorubicin + Ifosfamide | 02 | N | 280026803 | DOXORUBICIN + IFOSFAMIDE |
| 280012099 | 280005705 | 1 | 71.5 | Palliative (P) | null | 2019-12-28 | VAC | 2 | null | 280027822 | CAV |
| 280012100 | 280005761 | 1.71 | 116.5 | Adjuvant (A) | 2020-03-13 | 2020-03-13 | Etoposide + Ifosfamide (3 days) | 02 | N | 280028006 | ETOPOSIDE + IFOSFAMIDE |
| 280012101 | 280005860 | 1.7 | null | Palliative (P) | 2015-09-14 | 2016-05-07 | Carboplatin + Etoposide iv&po | N | N | 280028302 | CARBOPLATIN + ETOPOSIDE |
| 280012102 | 280005999 | 1.68 | 76.7 | Palliative (P) | 2016-08-24 | 2016-08-24 | Etoposide + Ifosfamide (5 days) | 2 | N | 280028766 | ETOPOSIDE + IFOSFAMIDE |
| 280012103 | 280006069 | null | 73.4 | Palliative (P) | null | 2018-03-07 | Etoposide + Ifosfamide (5 days) | 02 | null | 280029015 | ETOPOSIDE + IFOSFAMIDE |
| 280012104 | 280011937 | null | 77 | Curative (C) | 2018-09-21 | 2018-09-21 | CISPLATIN + FLUOROURACIL | N | N | 280029101 | CISPLATIN + FLUOROURACIL |
| 280012105 | 280009243 | 1.63 | 41.3 | Palliative (P) | 2019-11-28 | 2019-11-28 | EOX | 02 | N | 280029471 | PEMETREXED |
| 280012106 | 280006352 | 1.89 | 121 | Curative (C) | 2020-08-23 | 2020-09-02 | Docetaxel | 2 | N | 280030055 | DOCETAXEL |
| 280012107 | 280006425 | 1.64 | 16 | Palliative (P) | 2013-10-29 | 2014-06-08 | Y-90 | null | null | 280030215 | VIDE |
| 280012108 | 280006443 | 1.62 | 61 | Palliative (P) | 2019-04-27 | 2019-08-06 | FEC | 2 | N | 280030268 | TRASTUZUMAB |
| 280012109 | 280006481 | 1.52 | 6.3 | Palliative (P) | null | 2019-08-09 | ETOPOSIDE | 02 | null | 280030373 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280012110 | 280009392 | 0 | 62 | Palliative (P) | 2014-08-31 | 2014-08-31 | INTERFERON | N | N | 280030483 | VINCRISTINE |
| 280012111 | 280006575 | 1.61 | 15.7 | Palliative (P) | 2019-04-20 | 2019-06-20 | VINCRISTINE | 02 | N | 280030705 | CETUXIMAB + IRINOTECAN |
| 280012112 | 280010809 | 0 | null | Curative (C) | 2016-04-13 | 2016-08-22 | Capecitabine + Oxaliplatin 14day | N | N | 280020096 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE |
| 280012113 | 280006671 | null | 86 | Palliative (P) | 2019-09-20 | 2019-10-12 | Dactinomycin + Vincristine | N | N | 280020669 | CREATE TRIAL |
| 280012114 | 280006715 | 1.68 | 89.5 | Neo-adjuvant (N) | 2015-12-08 | 2015-12-09 | Capecitabine | null | null | 280023280 | CETUXIMAB + MDG |
| 280012115 | 280008556 | null | null | Palliative (P) | 2018-03-24 | 2018-11-10 | null | null | null | 280024896 | NOT MATCHED |
| 280012116 | 280004841 | 0 | 89 | Neo-adjuvant (N) | 2015-10-11 | 2015-11-01 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 280024927 | NOT MATCHED |